Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

Psychoneuroendocrinology - Tập 28 - Trang 139-168 - 2003
R. Rupprecht1,2
1Department of Psychiatry, Ludwig Maximilian University, Nußbaumstr. 7, 80336 Munich, Germany
2Max Planck Institute of Psychiatry, Munich, Germany

Tài liệu tham khảo

Akwa, 1992, Neurosteroid metabolism, 7 alpha-hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes, Biochem. J., 288, 959, 10.1042/bj2880959

Araneo, 1995, Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury, Endocrinology, 136, 393, 10.1210/endo.136.2.7835270

Azuma, 1999, The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia, J. Neurol. Sci., 162, 69, 10.1016/S0022-510X(98)00295-0

Barbaccia, 2001, Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat, Neuropsychopharmacology, 25, 489, 10.1016/S0893-133X(01)00254-8

Barbosa, 2001, Influence of neurosteroids on the development of rapid tolerance to ethanol in mice, Eur. J. Pharmacol., 431, 179, 10.1016/S0014-2999(01)01337-1

Barrantes, 2000, Nongenomic effects of steroids on the nicotinic acetylcholine receptor, Kidney Int., 57, 1382, 10.1046/j.1523-1755.2000.00979.x

Barrett-Connor, 1999, Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo study, J. Am. Geriatr. Soc., 47, 685, 10.1111/j.1532-5415.1999.tb01590.x

Baulieu, 1991, Neurosteroids: a new function in the brain, Biol. Cell., 71, 3, 10.1016/0248-4900(91)90045-O

Baulieu, 1998, Neurosteroids: a novel function of the brain, Psychoneuroendocrinology, 23, 963, 10.1016/S0306-4530(98)00071-7

Bäckström, 1984, Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy, Acta Neurol. Scand., 69, 240, 10.1111/j.1600-0404.1984.tb07807.x

Beekman, 1998, Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone, J. Pharmacol. Exp. Ther., 284, 868

Belelli, 1990, Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex, Neurosci. Biobehav. Rev., 14, 315, 10.1016/S0149-7634(05)80041-7

Bernardi, 2000, Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer’s disease and vascular dementia, Eur. J. Endocrinol., 142, 466, 10.1530/eje.0.1420466

Bicikova, 1998, Allopregnanolone in women with premenstrual syndrome, Horm. Metab. Res., 30, 227, 10.1055/s-2007-978871

Bicikova, 2000, Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder, Neurochem. Res., 25, 1623, 10.1023/A:1026622704704

Bitran, 1991, Anxiolytic effects of 3α-hydroxy-5α [β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor, Brain Res., 561, 157, 10.1016/0006-8993(91)90761-J

Bitran, 1995, Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors, J. Neuroendocrinol., 7, 171, 10.1111/j.1365-2826.1995.tb00744.x

Browne, 1993, Dehydroepiandrosterone regulation of the hepatic glucocorticoid receptor in the Zucker rat. The obesity research program, J. Steroid Biochem. Mol. Biol., 45, 517, 10.1016/0960-0760(93)90168-V

Bullock, 1997, Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes, J. Neurochem., 68, 2412, 10.1046/j.1471-4159.1997.68062412.x

Carl, 1990, Pregnanolone emulsion: a preliminary pharmacokinetic and pharmacodynamic study of a new intravenous agent, Anaesthesia, 45, 189, 10.1111/j.1365-2044.1990.tb14683.x

Carter, 1997, Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3-methyl-5α-pregnan-20-one), a selective high-affinity steroid modulator of the GABAA receptor, J. Pharmacol. Exp. Ther., 280, 1284

Celotti, 1992, The 5α-reductase in the brain: molecular aspects and relation to brain function, Front. Neuroendocrinol., 13, 163

Chen, 1994, Cloning and functional expression of a drosophila γ-aminobutyric acid receptor, Proc. Natl. Acad. Sci. USA, 91, 6069, 10.1073/pnas.91.13.6069

Compagnone, 2000, Neurosteroids: biosynthesis and function of these novel neuromodulators, Front. Neuroendocrinol., 21, 1, 10.1006/frne.1999.0188

Concas, 1998, Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery, Proc. Natl. Acad. Sci. USA, 95, 13284, 10.1073/pnas.95.22.13284

Crawley, 1986, Anxiolytic activity of an endogenous adrenal steroid, Brain Res., 398, 382, 10.1016/0006-8993(86)91500-3

Damianisch, 2001, The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat, Neuropsychopharmacology, 25, 576, 10.1016/S0893-133X(01)00242-1

Davies, 1999, The 5-HT3B subunit is a major determinant of serotonin-receptor function, Nature, 397, 359, 10.1038/16941

Devaud, 1995, The neurosteroid 3α-hydroxy-5α-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats, Alcohol. Clin. Exp. Res., 19, 350, 10.1111/j.1530-0277.1995.tb01514.x

Dong, 2001, Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation, Proc. Natl. Acad. Sci. USA, 98, 2849, 10.1073/pnas.051628598

van Doren, 2000, Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol, J. Neurosci., 20, 1982, 10.1523/JNEUROSCI.20-05-01982.2000

Edgar, 1997, CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat, J. Pharmacol. Exp. Ther., 282, 420

Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939

Fabian, 2001, Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults, Biol. Psychiatry, 50, 767, 10.1016/S0006-3223(01)01198-2

Flood, 1992, Memory-enhancing effects in male mice of pregnenolone and of steroids metabolically derived from it, Proc. Natl. Acad. Sci. USA, 89, 1567, 10.1073/pnas.89.5.1567

Flood, 1988, Dehydroepiandrosterone and its sulfate enhance memory retention in mice, Brain Res., 447, 269, 10.1016/0006-8993(88)91129-8

Friess, E., Tagaya, H., Trachsel, L., Holsboer, F., Rupprecht, R., 1997, Progesterone-induced changes in sleep in male subjects, Am J Physiol, 272, E885-E891.

Frye, 1994, Progesterone metatolites effective at the GABAA receptor complex modulate pain sensitivity in rats, Brain Res., 643, 194, 10.1016/0006-8993(94)90025-6

Frye, 2000, Anti-seizure effects of progesterone and 3α, 5α-THP in kainic acid and perforant pathway models of epilepsy, Psychoneuroendocrinology, 25, 407, 10.1016/S0306-4530(99)00068-2

Gasior, 1997, Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjuction with diazepam, J. Pharmacol. Exp. Ther., 282, 543

Gasior, 1999, Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders, Trends Pharmacol. Sci., 20, 107, 10.1016/S0165-6147(99)01318-8

Gee, 1988, Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependance and mechanism of action, J. Pharmacol. Exp. Ther., 246, 803

Girdler, 2001, Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder, Biol. Psychiatry, 49, 788, 10.1016/S0006-3223(00)01044-1

Grazzini, 1998, Inhibition of oxytocin receptor function by direct binding of progesterone, Nature, 392, 509, 10.1038/33176

Griffin, 1999, Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes, Proc. Natl. Acad. Sci. USA, 96, 13512, 10.1073/pnas.96.23.13512

Grobin, A.C., Morrow, A.L., 2000, 3α-hydroxy-5α-pregnan-20-one exposure reduces GABA(A) receptor α4 subunit mRNA levels, Eur. J. Pharmacol., 409, R1-R2.

Gyermek, 1975, Steroid anesthetics, Anesthesiology, 42, 116, 10.1097/00000542-197503000-00017

Halbreich, 2000, Selective estrogen receptor modulators-current and future brain and behavior applications, Expert Opin. Pharmacother., 1, 1385, 10.1517/14656566.1.7.1385

Hallonquist, 1993, Variation in symptom severity over the menstrual cycle of schizophrenics, Biol. Psychiatry, 33, 207, 10.1016/0006-3223(93)90141-Y

Häfner, 1993, Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia, Psychol. Med., 23, 925, 10.1017/S0033291700026398

Hermann, 2000, Pharmacological characterisation of cortical γ-aminobutyric acid A type A (GABAA) receptors in two Wistar rat lines selectively bred for high and low anxiety-related behaviour, World J. Biol. Psychiatry, 1, 137, 10.3109/15622970009150581

Herzog, 1995, Progesterone therapy in women with complex partial and secondary generalized seizures, Neurology, 45, 1660, 10.1212/WNL.45.9.1660

Heuser, 1998, Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients, J. Clin. Endocrinol. Metab., 83, 3130, 10.1210/jcem.83.9.5081

Hillen, 2000, DHEA-S plasma levels and incidence of Alzheimer’s disease, Biol. Psychiatry, 47, 161, 10.1016/S0006-3223(99)00217-6

Huppert, F.A., Niekerk, J.K., 2001, Dehydroepiandrosterone (DHEA) supplementation for cognitive function (Cochrane Review). Cochrane Database Syst. Rev., 2, CD000304.

Janis, 1998, Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in male and female rats, Alcohol. Clin. Exp. Res., 22, 2055

Khisti, 2000, Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test, Pharmacol. Biochem. Behav., 67, 137, 10.1016/S0091-3057(00)00300-2

Kliewer, 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway, Cell, 92, 73, 10.1016/S0092-8674(00)80900-9

Kokate, 1994, Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation, J. Pharmacol. Exp. Ther., 270, 1223

Korneyev, 1996, Allopregnanolone (THP) mediates anesthetic effects of progesterone in rats, Horm. Behav., 30, 37, 10.1006/hbeh.1996.0006

Korpi, 2001, Increased behavioral neurosteroid sensitivity in a rat line selectively bred for high alcohol sensitivity, Eur. J. Pharmacol., 421, 31, 10.1016/S0014-2999(01)01035-4

Kulkarni, 1996, A clinical trial of the effects of estrogen in acutely psychotic women, Schizophr. Res., 20, 247, 10.1016/0920-9964(96)82949-5

Kulkarni, 2001, Estrogen—a potential treatment for schizophrenia, Schizophr. Res., 48, 137, 10.1016/S0920-9964(00)00088-8

Ladurelle, 2000, Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse, Brain Res., 858, 371, 10.1016/S0006-8993(00)01953-3

Lambert, 1995, Neurosteroids and GABAA receptor function, Trends Pharmacol. Sci., 16, 295, 10.1016/S0165-6147(00)89058-6

Lancel, M., Faulhaber, J., Holsboer, F., Rupprecht, R., 1996, Progesterone induces changes in sleep EEG comparable to those of agonistic GABAA receptor modulators, Am J Physiol, 271, E763-E772.

Lancel, 1999, The GABAA receptor antagonist picrotoxin attenuates most of the sleep changes induced by progesterone, Psychopharmacology, 141, 213, 10.1007/s002130050827

Lancel, 1997, Allopregnanolone affects sleep in a benzodiazepine-like fashion, J. Pharmacol. Exp. Ther., 282, 1213

Le Melledo, 1999, Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases, Neuropsychopharmacology, 20, 81, 10.1016/S0893-133X(98)00057-8

Maayan, 2000, Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients, Biol. Psychiatry, 48, 693, 10.1016/S0006-3223(00)00848-9

Maitra, 1998, Modulation of GABAA receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABAA receptor isoforms, Can. J. Physiol. Pharmacol., 76, 909, 10.1139/y98-091

Maitra, 1999, Subunit dependent modulation of GABAA receptor function by neuroactive steroids, Brain Res., 819, 75, 10.1016/S0006-8993(98)01316-X

Majewska, 1986, Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor, Science, 232, 1004, 10.1126/science.2422758

Maricq, 1991, Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel, Science, 254, 432, 10.1126/science.1718042

Marx, 2000, Olanzapine increases allopregnanolone in the rat cerebral cortex, Biol. Psychiatry, 47, 1000, 10.1016/S0006-3223(99)00305-4

McEwen, 1991, Non-genomic and genomic effects of steroids on neural activity, Trends Pharmacol. Sci., 12, 141, 10.1016/0165-6147(91)90531-V

Mellon, 1994, Neurosteroids: biochemistry, modes of action and clinical relevance, J. Clin. Endocrinol. Metab., 78, 1003

Mendelson, 1987, Sleep induction by an adrenal steroid in the rat, Psychopharmacology, 93, 226, 10.1007/BF00179939

Molina-Hernández, 2001, Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim, Psychoneuroendocrinology, 26, 479, 10.1016/S0306-4530(01)00007-5

Monaghan, 1999, Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy, Expert Opin. Invest. Drugs, 8, 1663, 10.1517/13543784.8.10.1663

Monaghan, 1997, Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity, Epilepsia, 38, 1026, 10.1111/j.1528-1157.1997.tb01486.x

Monnet, 1995, Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus, Proc. Natl. Acad. Sci. USA, 92, 3774, 10.1073/pnas.92.9.3774

Monteleone, 2000, Allopregnanlone concentrations and premenstrual syndrome, Eur, J. Endocrinol., 142, 269

Moore, 2000, St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor, Proc. Natl. Acad. Sci. USA, 97, 7500, 10.1073/pnas.130155097

Murialdo, 2001, Relationships between cortisol, dehydroepiansrosterone sulphate and insulin-like growth factor-1 system in dementia, J. Endocrinol. Invest., 24, 139, 10.1007/BF03343833

Nadeson, 2001, Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically, Br. J. Anaesth., 86, 704, 10.1093/bja/86.5.704

Näsman, 1991, Serum dehydroepiandrosterone sulfate in Alzheimer’s disease and in multiinfarct dementia, Biol. Psychiatry, 30, 684, 10.1016/0006-3223(91)90013-C

van Niekerk, 2001, Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation, Psychoneuroendocrinology, 26, 591, 10.1016/S0306-4530(01)00014-2

Orchinik, 1991, A corticosteroid receptor in neuronal membranes, Science, 252, 1848, 10.1126/science.2063198

Pappas, 1995, Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding, FASEB J., 9, 404, 10.1096/fasebj.9.5.7896011

Park-Chung, 1994, 3α-hydroxy -5beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons, Mol. Pharmacol., 46, 146

Patchev, 1997, Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neurondocrine consequences of adverse early life events, J. Clin. Invest., 99, 962, 10.1172/JCI119261

Patchev, 1994, The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus, Neuroscience, 62, 265, 10.1016/0306-4522(94)90330-1

Paul, 1992, Neuroactive steroids, FASEB J., 6, 2311, 10.1096/fasebj.6.6.1347506

Pearson Murphy, 2001, Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy, J. Clin. Endocrinol. Metab., 86, 5981

Prince, 1992, 5β-pregnan-3β-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor-complex, Neurosci. Lett., 135, 273, 10.1016/0304-3940(92)90454-F

Puia, 1990, Neurosteroids act on recombinant human GABAA receptors, Neuron, 4, 759, 10.1016/0896-6273(90)90202-Q

Ramirez, 1996, Membrane sex-steroid receptors in the brain, Front. Neuroendocrinol., 17, 402, 10.1006/frne.1996.0011

Rapkin, 1997, Progesterone metabolite allopregnanolone in women with premenstrual syndrome, Obstet. Gynecol., 90, 709, 10.1016/S0029-7844(97)00417-1

Rasgon, 2001, Neuroactive steroid-serotonergic interaction: responses to an intravenous l-tryptophan challenge in women with premenstrual syndrome, Eur. J. Endocrinol., 145, 25, 10.1530/eje.0.1450025

Reddy, 2000, Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself, J. Pharmacol. Exp. Ther., 295, 1241

Rick, 1998, Neurosteroids act on the GABA(A) receptor at sites on the N-terminal side of the middle of TM2, Neuroreport, 9, 379, 10.1097/00001756-199802160-00004

Romeo, 1996, Marked decrease of plasma neuroactive steroids during alcohol withdrawal, Clin. Neuropharmacol., 19, 366, 10.1097/00002826-199619040-00011

Romeo, 2000, Effects of fluoxetine, indomethacine and placebo on 3α, 5α tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal, World J. Biol. Psychiatry, 1, 101, 10.3109/15622970009150572

Romeo, 1998, Effects of antidepressant treatment on neuroactive steroids in major depression, Am. J. Psychiatry, 155, 910, 10.1176/ajp.155.7.910

Rupprecht, 1997, The neuropsychopharmacological potential of neuroactive steroids, J. Psychiatr. Res., 31, 297, 10.1016/S0022-3956(96)00060-X

Rupprecht, 1996, Steroid receptor mediated effects of neuroactive steroids: characterization of structure-activity relationship, Eur. J. Pharmacol., 303, 227, 10.1016/0014-2999(96)00036-2

Rupprecht, 1999, Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives, Trends Neurosci., 22, 410, 10.1016/S0166-2236(99)01399-5

Rupprecht, 1999, Assessment of neuroleptic-like properties of progesterone, Psychopharmacology, 143, 29, 10.1007/s002130050916

Rupprecht, 1993, Progesterone receptor-mediated effects of neuroactive steroids, Neuron, 11, 523, 10.1016/0896-6273(93)90156-L

Schulz, 1996, Soporific effect of the neurosteroid pregnanolone in relation to the substance’s plasma level: a pilot study, Neuropsychobiology, 34, 106, 10.1159/000119300

Serra, 2000, Steroidogenesis in rat brain induced by short- and long-term administration of carbamazepine, Neuropharmacology, 39, 2448, 10.1016/S0028-3908(00)00086-1

Serra, 2001, Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain, Psychopharmacology, 158, 48, 10.1007/s002130100853

Smith, 1998, GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid, Nature, 392, 926, 10.1038/31948

Smith, 1998, Withdrawal from 3α-OH- 5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety, J. Neurosci., 18, 5275, 10.1523/JNEUROSCI.18-14-05275.1998

Sooksawate, 2001, Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators, Br. J. Pharmacol., 134, 1303, 10.1038/sj.bjp.0704360

Steiner, 1995, Fluoxetine in the treatment of premenstrual dysphoria, N. Engl. J. Med., 332, 1529, 10.1056/NEJM199506083322301

Ströhle, 2000, Fluoxetine decreases concentrations of 3α, 5α-tetrahydrodeoxycorticosterone (THDOC) in major depression, J. Psychiatr. Res., 34, 183, 10.1016/S0022-3956(00)00006-6

Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Hermann, B., Gajewski, G., Holsboer, F., Rupprecht, R. Induced panic attacks shift GABAA receptor modulatory steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry, in press.

Ströhle, 2002, GABAA receptor modulatory neuroactive steroid composition in panic disoder and during paroxetine treatment, Am. J. Psychiatry, 159, 145, 10.1176/appi.ajp.159.1.145

Ströhle, 1999, Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery, Biol. Psychiatry, 45, 247, 10.1016/S0006-3223(98)00328-X

Strous, 2001, Analysis of neurosteroid levels in attention deficit hyperactivity disorder, Int. J. Neuropsychoparmacol., 4, 259

Su, 1988, Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems, Science, 240, 219, 10.1126/science.2832949

Sunderland, 1989, Reduced plasma dehydroepiandrosterone concentrations in Alzheimer’s disesase, Lancet, II, 570, 10.1016/S0140-6736(89)90700-9

Sundström, 1998, Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial, Psychoneuroendocrinology, 23, 73, 10.1016/S0306-4530(97)00064-4

Tecott, 1993, A new wave of serotonin receptors, Curr. Opin. Neurobiol., 3, 310, 10.1016/0959-4388(93)90122-F

Thomas, 1994, Serum dehydroepiandrosterone sulfate levels as an individual marker, J. Clin. Endocrinol. Metab., 79, 1273

Truss, 1993, Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors, Endocrine Rev., 14, 459

Uzunov, 1996, Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography, Proc. Natl. Acad. Sci. USA, 93, 12599, 10.1073/pnas.93.22.12599

Uzunova, 1998, Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine, Proc. Natl. Acad. Sci. USA, 95, 3239, 10.1073/pnas.95.6.3239

Valera, 1992, Progesterone modulates a neuronal nicotinic acetylcholine receptor, Proc. Natl. Acad. Sci. USA, 89, 9949, 10.1073/pnas.89.20.9949

Vallee, 1997, Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus, Proc. Natl. Acad. Sci. USA, 94, 14865, 10.1073/pnas.94.26.14865

Vanover, 2000, Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3α, 21-dihydroxy-3β-trifluoromethyl-19-nor-5β-pregnan-20-one), a selective modulator of γ-aminobutyric acidA receptors, J. Pharmacol. Exp. Ther., 295, 337

Weaver, 1997, Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-d-aspartate receptor, Proc. Natl. Acad. Sci. USA, 94, 10450, 10.1073/pnas.94.19.10450

Weaver, 1997, 17β-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors, Brain Res., 761, 338, 10.1016/S0006-8993(97)00449-6

Wehling, 1997, Specific, nongenomic actions of steroid hormones, Annu. Rev. Physiol., 59, 365, 10.1146/annurev.physiol.59.1.365

Wetzel, 1998, Functional antagonism of gonadal steroids at the 5-HT3 receptor, Mol. Endocrinol., 12, 1441, 10.1210/mend.12.9.0163

Wieland, 1991, Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one, Brain Res., 565, 263, 10.1016/0006-8993(91)91658-N

Wolf, 1998, Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor, Psychoneuroendocrinology, 23, 617, 10.1016/S0306-4530(98)00032-8

Wolkowitz, 1999, Double-blind treatment of major depression with dehydroepiandrosterone, Am. J. Psychiatry, 156, 646, 10.1176/ajp.156.4.646

Wolkowitz, 1997, Dehydroepiandrosterone (DHEA) treatment of depression, Biol. Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1

Wu, 1990, Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone, Mol. Pharmacol., 37, 597

Wu, 1991, Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor, Mol. Pharmacol., 40, 333

Zakon, 1998, The effects of steroid hormones on electrical activity of excitable cells, Trends Neurosci., 21, 202, 10.1016/S0166-2236(97)01209-5

Zorumski, 2000, Potential clinical uses of neuroactive steroids, Curr. Opin. Invest. Drugs, 1, 360

Thông tin
Thông tin xuất bản

Psychoneuroendocrinology

Tập 28

139-168

Thông tin tác giả